Inception Therapeutics is a multi-disciplinary discovery engine founded in 2011 with Versant Ventures to build and launch transformative new biotechnology companies. The firm is an established leader in new company creation with integrated expertise in chemistry, biology, and DMPK.
2011
Privately held, in collaboration with Versant Ventures.
San Diego, CA, United States
About
Mission
To develop novel treatments for unmet medical needs by leveraging scientific breakthroughs and technology platforms across multiple therapeutic areas.
Values
Innovation, scientific excellence, and addressing significant healthcare challenges.
Participant Demographics
Focus on unmet medical needs across multiple therapeutic areas.
Track Record
Team Experience
Extensive experience in drug discovery and company creation. Leadership team includes prominent figures such as Richard Glynne (President & Chief Scientific Officer) and Don Hertzog (Head of Chemistry).
Notable Achievements
Launched seven companies that raised over $250 million in funding.
Project Track Record
Companies like Tempest Therapeutics, Chinook Therapeutics, and Pipeline Therapeutics showcase successful biotech ventures.
Get Full Profile
Access complete investment history, team details, portfolio companies, and direct contact information.
Unlock Full AccessHeadquarters
San Diego, CA, United States
Access 150,000+ investor profiles
Get complete access to our database of investment firms with detailed profiles, contact information, investment preferences, and AI-powered matching.